Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Inflammatory Markers and Mircera® Prospective Assessment of Correlation (IMPACT): A Multi-Center Observational Study Investigating the Correlation Between Inflammatory Marker Levels and ESA Dosage in CKD Patients on Dialysis Treated With Mircera®

NCT02238080 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT02238080
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02238080 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Inflammatory Markers and Mircera® Prospective Assessment of Correlation (IMPACT): A Multi-Center Observational Study Investigating the Correlation Between Inflammatory Marker Levels and ESA Dosage in CKD Patients on Dialysis Treated With Mircera®
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
December 31, 2009
Completion date
June 30, 2012
Enrollment
197 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney diseases